Loading...
Critical evaluation of ceftolozane–tazobactam for complicated urinary tract and intra-abdominal infections
The rise in resistant Gram-negative pathogens continues to challenge clinicians treating infections. These resistant infections have inspired the development of new antimicrobial agents, including ceftolozane–tazobactam, a novel β-lactam/β-lactamase inhibitor combination approved by the US Food and...
Na minha lista:
| Udgivet i: | Ther Clin Risk Manag |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4878668/ https://ncbi.nlm.nih.gov/pubmed/27279744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S83844 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|